The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractCRISPR-Cas is a rapidly evolving RNA-mediated adaptive immune system that protects bacteria and archaea against mobile genetic elements. The system relies on the activity of short mature CRISPR RNAs (crRNAs) that guide Cas protein(s) to silence invading nucleic acids. A set of CRISPR-Cas, type II, requires a trans-activating small RNA, tracrRNA, for maturation of precursor crRNA (pre-crRNA) and interference with invading sequences. Following co-processing of tracrRNA and pre-crRNA by RNase III, dual-tracrRNA:crRNA guides the CRISPR-associated endonuclease Cas9 (Csn1) to cleave site-specifically cognate target DNA. Here, we screened available genomes for type II CRISPR-Cas loci by searching for Cas9 orthologs. We analyzed 75 representative loci, and for 56 of them we predicted novel tracrRNA orthologs. Our analysis demonstrates a high diversity in cas operon architecture and position of the tracrRNA gene within CRISPR-Cas loci. We observed a correlation between locus heterogeneity and Cas9 sequence diversity, resulting in the identification of various type II CRISPR-Cas subgroups. We validated the expression and co-processing of predicted tracrRNAs and pre-crRNAs by RNA sequencing in five bacterial species. This study reveals tracrRNA family as an atypical, small RNA family with no obvious conservation of structure, sequence or localization within type II CRISPR-Cas loci. The tracrRNA family is however characterized by the conserved feature to base-pair to cognate pre-crRNA repeats, an essential function for crRNA maturation and DNA silencing by dual-RNA:Cas9. The large panel of tracrRNA and Cas9 ortholog sequences should constitute a useful database to improve the design of RNA-programmable Cas9 as genome editing tool.
CitationThe tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. 2013, 10 (5):726-37 RNA Biol
AffiliationThe Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå Centre for Microbial Research (UCMR), Department of Molecular Biology, Umeå University, Umeå, Sweden.
The following license files are associated with this item:
- The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
- Authors: Fonfara I, Richter H, Bratovič M, Le Rhun A, Charpentier E
- Issue date: 2016 Apr 28
- crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus.
- Authors: Karvelis T, Gasiunas G, Miksys A, Barrangou R, Horvath P, Siksnys V
- Issue date: 2013 May
- A scoutRNA Is Required for Some Type V CRISPR-Cas Systems.
- Authors: Harrington LB, Ma E, Chen JS, Witte IP, Gertz D, Paez-Espino D, Al-Shayeb B, Kyrpides NC, Burstein D, Banfield JF, Doudna JA
- Issue date: 2020 Aug 6
- Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
- Authors: Charpentier E, Richter H, van der Oost J, White MF
- Issue date: 2015 May
- Approaches to study CRISPR RNA biogenesis and the key players involved.
- Authors: Behler J, Hess WR
- Issue date: 2020 Feb 1